The difference between semaglutide and liraglutide is that semaglutide is more effective for some individuals and more ...

Compounding facility ProRx Pharmacy Network has received an FDA warning letter over issues with its semaglutide and ...

In 2024, a warning by the U.S. Food and Drug Administration (FDA) focused on the potential dangers of compounded semaglutide and tirzepatide, with the agency citing reports of unanticipated health ...

Researchers also examined differences in physical activity benefits between men and women. New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...

GLP-1 drugs such as semaglutide and tirzepatide are at the center of a weight-loss drug revolution. The biggest development in weight-loss medicine since bariatric surgery (not to mention less ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been ... loss in the control group. A key difference between SUMMIT and Novo Nordisk's STEP-HFpEF study of semaglutide is that it included ...

So, how does Mounjaro work? Tirzepatide works similarly to semaglutide. The difference here is that tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a GLP-1 ...